156 studies found for:    Non-Alcoholic Steatohepatitis
Show Display Options
Rank Status Study
21 Completed Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Intervention: Drug: TRO19622
22 Active, not recruiting Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Condition: Non-cirrhotic Non-alcoholic Steatohepatitis
Interventions: Other: Placebo;   Drug: Silymarin
23 Enrolling by invitation Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: Colesevelam Hcl
24 Completed Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Pioglitazone;   Drug: Placebo
25 Recruiting Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Intervention: Drug: Ezetimibe
26 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo
27 Unknown  Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes;   Nonalcoholic Steatohepatitis
Interventions: Drug: sitagliptin;   Drug: placebo
28 Unknown  Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children
Condition: Non-Alcoholic Steatohepatitis
Intervention:
29 Not yet recruiting Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin
Condition: Non-alcoholic Steatohepatitis
Intervention: Radiation: Tc 99m MEB
30 Withdrawn Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: IMM 124-E;   Biological: Placebo
31 Completed A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Intervention: Drug: rosiglitazone
32 Unknown  Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
Conditions: Sleep Apnea Syndrome;   Nonalcoholic Steatohepatitis
Intervention: Device: nCPAP
33 Unknown  Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: pentoxiphylline and Vitamin E;   Drug: Vitamin E
34 Unknown  Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: Vitamin E plus Pentoxiphyllin;   Drug: Vitamin E
35 Completed Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-Alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Intervention: Other: NRL972
36 Completed The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: synbiotic;   Other: placebo
37 Completed Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: GS-9450;   Drug: GS-9450 Placebo
38 Recruiting The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: S-adenosylmethionine (SAMe);   Drug: pentoxiphylline (PTX)
39 Completed Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers
Conditions: Hepatic Cirrhosis;   Nonalcoholic Steatohepatitis
Intervention: Drug: NRL972
40 Completed A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: ASP9831;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years